Echocardiography + Electrocardiogram (ECG) + DEFERIPRONE + Deferoxamine + Deferasirox for iron overload

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Jun 2025: Trial registered, NCT07023666
  2. 7 Oct 2025: Trial started, NCT07023666

The trials

NCT07023666: Early Screening and Treatment of Heart Complication in Sickle Cell Disease

State
Under way
Phase
Phase 2
People
100 planned
Started
7 Oct 2025
Primary completion
30 Jun 2027
Arms
Intervention for Cardiac Iron Overload in Sickle Cell Patients
Results
None posted
  1. 17 Jun 2025: Trial registered
  2. 7 Oct 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.